Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeSurgical Innovation Associates

Surgical Innovation Associates

Surgical Innovation Associates Reports 1st US Patient Implanted in Pivotal IDE Study of DuraSorb Monofilament Mesh Use in Prosthetic Breast Reconstruction

The study will evaluate the safety and effectiveness of DuraSorb® for reinforcement in prosthetic breast reconstruction.

Surgical Innovation Associates Receives FDA 510(k) Clearance to Market Advanced Bioabsorbable Mesh for Reconstructive and Cosmetic Surgery

Each year, more than 1 million Americans are implanted with surgical mesh to provide the soft tissue support that is necessary in a variety of general and plastic surgical procedures. Much like an absorbable stitch, DuraSorbTM Monofilament Mesh is designed to integrate into the patient’s tissue – providing strong support during the critical initial phases of healing – and then slowly dissolve, leaving the patient free from foreign material within one year.

Surgical Innovation Associates: Receives FDA 510(k) Clearance to Market DuraSorb Monofilament Mesh

Much like an absorbable stitch, DuraSorbTM Monofilament Mesh is designed to integrate into the patient’s tissue, providing strong support during the critical initial phases of healing, and then slowly dissolve, leaving the patient free from foreign material within one year.

By using this website you agree to accept Medical Device News Magazine Privacy Policy